Top
Begin typing your search above and press return to search.

Roche Diagnostics gets green signal for COVID antibody test

Roche Diagnostics India welcomed Indian Council of Medical Research’s communication regarding its COVID-19 antibody test

Roche Diagnostics for COVID antibody test

Sentinel Digital DeskBy : Sentinel Digital Desk

  |  2 Jun 2020 5:18 AM GMT

New Delhi: Roche Diagnostics India on Monday said it welcomed Indian Council of Medical Research's communication regarding its COVID-19 antibody test for seroprevalence studies in India.

Dr Shravan Subramanyam, Managing Director, Roche Diagnostics India said, "Roche Diagnostics India welcomes ICMR's communication that cites making available Roche COVID-19 antibody test for seroprevalence studies in India."

According to Subramanyam, the study includes those on high-risk groups like healthcare workers - to plan the country's pandemic management efforts in the future. The lab-based antibody test that runs on fully automated Chemiluminescence Immunoassay (CLIA) analysers with estimated peak testing capacity of 0.5 million tests a day is being made available across National Accreditation Board for Testing and Calibration Laboratories (NABL) approved and government sites in India.

The Elecsys Anti-SARS-CoV-2 serology test that supports detection of antibodies against SARS-CoV-2 has received the Import License issued by the Central Drug Standard Control Organization (CDSCO), due to the emergency health situation in the public interest. (IANS)

Also watch: Ninong Ering, MLA, East Siang, Arunachal Pradesh in an exclusive chat with Oineetom

Next Story